Zheng Bai-Yu BY

Show results for

Unknown (132)
Proteomics (2)
Genomics (1)
Metabolomics (1)

Organisms

Homo sapiens (3)

Repository

pride (2)
EGA (1)
MetaboLights (1)

Tissue

Cell culture (1)
Vitreous humor (1)

Technology Type

Mass Spectrometry (2)
Mass spectrometry (1)
Data-dependent acquisition (1)
Shotgun proteomics (1)

Instrument Platform

Liquid Chromatography MS - Negative (LC-MS (NEG)) (1)
Liquid Chromatography MS - Positive (LC-MS (POS)) (1)

Publication Date

2019 (1)
2024 (1)
2018 (1)

CHEBI ID

CHEBI:15355 (1)
CHEBI:15603 (1)
CHEBI:15676 (1)
CHEBI:15727 (1)
CHEBI:15756 (1)
CHEBI:15824 (1)
CHEBI:15843 (1)
CHEBI:15971 (1)
CHEBI:16010 (1)
CHEBI:16015 (1)
CHEBI:16024 (1)
CHEBI:16196 (1)
CHEBI:16347 (1)
CHEBI:16349 (1)
CHEBI:16414 (1)
CHEBI:16467 (1)
CHEBI:16525 (1)
CHEBI:16704 (1)
CHEBI:16755 (1)
CHEBI:16828 (1)
CHEBI:16870 (1)
CHEBI:16919 (1)
CHEBI:16946 (1)
CHEBI:16990 (1)
CHEBI:17154 (1)
CHEBI:17191 (1)
CHEBI:17203 (1)
CHEBI:17351 (1)
CHEBI:17490 (1)
CHEBI:17687 (1)

Metabolite Name

1-Methylhistidine (1)
2-Methylglutaric acid (1)
5-Hydroxyindoleacetate (1)
5-Oxoproline (1)
Acetylcholine (1)
Bilirubin (1)
Chenodeoxycholate (1)
Creatine (1)
D-Mannose (1)
Glycerophosphocholine (1)
Glycodeoxycholic acid (1)
L-Arginine (1)
L-Carnitine (1)
L-Carnosine (1)
L-Citrulline (1)
L-Histidine (1)
L-Kynurenine (1)
L-Norleucine (1)
L-Palmitoylcarnitine (1)
L-Pipecolic acid (1)
L-Proline (1)
LysoPC(14:0) (1)
LysoPC(16:0) (1)
LysoPC(18:0) (1)
LysoPC(18:1(9Z)) (1)
N-Oleoylethanolamine (1)
Nicotinamide (1)
Ornithine (1)
Phenylacetylglycine (1)
Phosphatidylcholine(36:1) (1)

Release Date

2025 (27)
2022 (17)
2024 (16)
2023 (15)
2020 (14)
2018 (10)
2021 (9)
2015 (7)
2026 (5)
2019 (5)
2016 (4)
2017 (3)

Lab affiliation

Department of Ophthalmology, Shanghai General Hospital; Shanghai Key Laboratory of Ocular Fundus Disease; Shanghai Engineering Center for Visual Science and Photomedicine, No. 100 Haining Road, Shanghai 200080, China. (1)
Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical Sciences (1)

Previous page
1 / 14
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 14
Next page

Sort by:

Relevance

Page size

Change of Ranibizumab-induced Human Vitreous Protein Profile in Patients with Proliferative Diabetic Retinopathy Based on Proteomics Analysis

Background: Preoperative treatment of anti-vascular endothelial growth factor (VEGF) agents is extensively used in proliferative diabetic retinopathy (PDR), but the molecular mechanism is not fully understood. The objective of this research is to observe change of protein profile induced by Ranibizu...

ORGANISM(S): Homo sapiens (Human)

2018-10-19 | PXD008901 | Pride